BUSCHER, DIRK,GONZALEZ DE LA PENA, MANUEL ANGEL,DELGADO MORA, MARIO
申请号：
AU2018253517
公开号：
AU2018253517A1
申请日:
2018.10.24
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018253517A120181115.pdf#####ABSTRACT The present invention provides a population of connective tissue derived cells that respond to interferon-gamma (IFN-y) by expressing indolamine-2,3-dioxygenase (IDO) for use in preventing, treating or ameliorating one or more symptoms associated with disorders in which modulation of a subject's immune system is beneficial, including, but not limited to, autoimmune diseases, inflammatory disorders, and immunologically mediated diseases including rejection of transplanted organs and tissues.
